News
The decision affects THR-687, a pan RGD integrin antagonist for the treatment ... who do not respond to treatment with blockbuster anti-VEGF drugs like Bayer/Regeneron's Eylea (aflibercept ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback